Stereotactic Radiosurgery for Melanoma Brain Metastases in Patients Receiving Ipilimumab: Safety Profile and Efficacy of Combined Treatment

PURPOSE: Ipilimumab (Ipi), a monoclonal antibody against cytotoxic T-lymphocyte antigen-4, has been shown to improve survival in patients with metastatic melanoma. In this single-institution study, we investigate the safety and efficacy of stereotactic radiosurgery (SRS) for patients with melanoma b...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Radiat Oncol Biol Phys
Autors principals: Kiess, Ana P., Wolchok, Jedd D., Barker, Christopher A., Postow, Michael A., Tabar, Viviane, Huse, Jason T., Chan, Timothy A., Yamada, Yoshiya, Beal, Kathryn
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4955924/
https://ncbi.nlm.nih.gov/pubmed/25754629
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2015.01.004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars